Emerging data suggest this peptide, a dual activator targeting check here both the gut-brain axis and GIP , could offer a notable advancement for obesity treatment. Early clinical investigations have indicated considerable decreases in abdominal fat , potentially surpassing current body composition therapies . However , additional evaluation is nee